The Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Mild Hypertension
Clinical trial NCT00562809 · COMPLETED
Trial details
- NCT number
- NCT00562809
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-07-01
- Enrollment
- 1005
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.